AstraZeneca reprimanded over LinkedIn likes once again FiercePharma 21h LinkedIn Pharma Top Internet Brands
Encouraging trial results for AstraZeneca's new weight-loss pill France 24 1d Novo Nordisk Pharma Diet and Fitness
Ada 2026: AstraZeneca advances oral GLP-1 elecoglipron into Phase III after positive trial data Scrip Pharma Intelligence 1d Pharma
AstraZeneca's obesity drug shows promise as analysts see upside beyond consensus Invezz 18h Obesity Novo Nordisk Pharma
AstraZeneca anunță un nou medicament pentru slăbit pe care l-a dezvoltat și care a trecut cu succes de faza studiilor clinice. Medicamentul a ajutat pacienții să piardă până la 12% din greutatea corporală în aproximativ nouă luni. Biziday 15h
STAT Plus: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more STAT 18h
Incyte Acquires Vega In Hematology-Focused Diversification Plan Scrip Pharma Intelligence 2d Mergers and Acquisitions
SK Biopharmaceuticals opens New Jersey hub for Korean biotech firms Investment Monitor 2d New Jersey Biotech Biotechnology
Roche signs $2.3bn blood cancer drug agreement with Nurix Therapeutics Pharmaceutical Technology 2d Roche Cancer Cancer Treatment
